// App-Quantinova.ai

P183 : Assessing the safety of treatment cessation in Takayasu arteritis

Researchers

Presenter

  • Chanaka Dahanayake

Principal Investigators

  • Robert Maughan

  • Taryn Youngstein

  • Justin C Mason

Medical Centers

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Takayasu arteritis

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved